
Aidoc is a global leader in clinical AI focused on helping physicians make earlier, safer diagnoses by turning raw patient signals into actionable insight. The company is powered by its breakthrough CARE foundation model and an enterprise AI platform, Aidoc aiOS, embedding AI directly into clinical workflows, enabling health systems to deploy, manage and scale multiple FDA-cleared solutions through a centralized operating layer. Aidoc's technology has analyzed more than 110 million patient cases and is deployed in nearly 2,000 hospitals worldwide, supporting clinical decision-making for approximately 60 million patients each year.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 04/29/26 | $150,000,000 | Series E |
General Catalyst Partners Goldman Sachs ![]() NVentures SoftBank Investment Advisers | undisclosed |